Join to View Full Profile
7720 S Broadway500Littleton, CO 80122
Phone+1 303-733-8848
Fax+1 303-733-0106
Dr. Fagelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- James Fagelson, MD, is a urologist based in Littleton, CO, with subspecialties in minimally invasive surgery, stone disease, and surgical oncology. He completed his medical education at the University of Texas Southwestern Medical School in 1994, followed by a surgery residency from 1994 to 1996 and a urology residency from 1996 to 2000 at the University of Texas Southwestern Medical Center. Dr. Fagelson is experienced in urologic oncology, minimally invasive urologic surgery, erectile dysfunction, testicular cancer, and kidney and ureteral stones. He has published several studies, including a notable one on the 'prostatic urethral lift' in BJU International, cited 73 times. His accolades include CMS Meaningful Use Stage 1 and Stage 2 Certifications, membership in Phi Beta Kappa and Alpha Omega Alpha, and a fellowship with the American College of Surgeons.
Education & Training
University of Texas Southwestern Medical CenterResidency, Urology, 1996 - 2000- University of Texas Southwestern Medical CenterResidency, Surgery, 1994 - 1996
University of Texas Southwestern Medical SchoolClass of 1994
Certifications & Licensure
CO State Medical License 2000 - 2027
TX State Medical License 1995 - 2001
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts Professional EHR, Allscripts, 2013-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013-2017
- Phi Beta Kappa
Publications & Presentations
PubMed
- 76 citationsMulticentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Anthony L. Cantwell, William Bogache, Steven F. Richardson, Ronald F. Tutrone, Jack Barkin
BJU International. 2014-04-01 - 21 citationsMyosin heavy chain gene expression in normal and hyperplastic human prostate tissue.Victor K. Lin, Di Wang, I-Ling Lee, Dolores Vasquez, James E. Fagelson
The Prostate. 2000-08-01
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
